• 대한한의학회지
• /
• 제28권1호통권69호
• /
• pp.87-93
• /
• 2007

Objectives : This study was to assess the effectiveness of Oriental medical treatment on carpal tunnel syndrome, comparing its outcome with that of Western medical treatment. Methods : After being diagnosed with carpal tunnel syndrome by electromyography, subjects were enrolled in Kyung Hee Medical Center from March 2006 to January 2007. We prescribed Kejibokryung-hwan to the Oriental medical therapy group (OM group) and NSAIDS to the Western medical therapy group (WM group). Effectiveness was assessed by degree of pain using visual analog scale (VAS) before and after 3 weeks' treatment. Adverse effects were also monitored. Results : There were 21 patients in the OM group and 19 in the WM group. No statistical significant difference was detected at the baseline assessment. After 3 weeks of medication, pain was reduced about 26% in the OM group and 46% in the WM group. These findings might be explained by that more than half of the WM group received local steroid injection, which has been known to have more rapid analgesic effect that oral medication. Although pain reduction rate was higher in the WM group than in the OM group, we suggest that Oriental medical treatment is still effective, faking into consideration the fact that completely recovered cases were found only in the OM group. No adverse effect was found in either of the groups. Conclusion : This work could help us to understand the effectiveness of Oriental medical treatment on carpal tunnel syndrome.

• Journal of Acupuncture Research
• /
• 제27권1호
• /
• pp.117-127
• /
• 2010

Background : To demonstrate the efficacy of moxibustion therapy, randomized controled trials are required. But, clinical trials of moxibustion had limitations due to the absence of a sham moxibustion model for an appropriate placebo. Objectives : To develop a new sham moxibustion model based on the thermal characteristics of commercial indirect moxibustion, especially temperature, and to evaluate whether it could be applied in clinical trials. Methods : By applying heat insulation, we created a sham moxibustion device that was indistinguishable from a real one with the naked eye. It also stimulated heat but had inert remedial value. A clinical trial was performed on subjects to test double blinding. The subjects were randomly assigned into two groups, a treatment group and a sham group. Acupoint Zusanli($ST_{36}$) was used in each group for 3 times. A sham acupuncture credibility questionnaire was modified into a moxibustion credibility questionnaire and was filled out after treatment. Results : No major difference was detected in the subjects' baseline data. Most subjects and practitioners could not distinguish the sham moxibustion device from the real one. But, subjects who had experience of moxibustion therapy more likely to distinguish the sham moxibustion device from the real one than subjects who didn't have experience of moxibustion therapy. The treatment group showed a significant difference in the VAS(Visual Analog Scale) for intensity of sensation during treatment than that of the sham group. Conclusions : The sham moxibustion device in this study is proved sufficient and credible to be applied in investigations of the effect of moxibustion. But it is more appropriate for the people who don't have experience of moxibustion therapy.

• Maxillofacial Plastic and Reconstructive Surgery
• /
• 제42권
• /
• pp.14.1-14.11
• /
• 2020

Background: The purpose of this study is to introduce our modified disc plication technique using MITEK mini anchors and to evaluate the clinical outcome for patients with internal derangement (ID) of the temporomandibular joint (TMJ). Patients and methods: We evaluated 65 joints in 46 patients, comprised 32 women and 14 men, who first visited the Asan Medical Center from December 2012 to December 2016. The age of the patients ranged from 14 to 79 years, with a mean age of 36.6 years. The patients presented with joint problems including pain, joint noise, and mouth opening limitation (MOL). Patients who met our inclusion criteria underwent unilateral or bilateral disc repositioning surgery with our minimally invasive disc plication technique using MITEK mini anchors and No. 2-0 Ethibond^® braided polyester sutures. The variables taken into account in this study were the range of maximum mouth opening (MMO), painful symptoms (evaluated with the visual analog scale, VAS), and the type of noise (click, popping, crepitus) in the TMJ. Results: Preoperative examination revealed painful symptoms in 50.7% (n = 35) of the operated joints (n = 69) and the presence of clicks in 56.5% (n = 39). Postoperative examination revealed that 4.3% (n = 3) of the operated joints had painful symptoms with lower intensity than that in the preoperative condition. Additionally, 17.4% (n = 12) had residual noise in the TMJ, among which two were clicking and the other 10 had mild crepitus. The intensity of the postoperative residual noise was significantly decreased in all cases compared to that in the preoperative condition. Among patients with MOL below 38 mm (n = 18), the mean MMO was 31.4 mm preoperatively and 44.2 mm at 6 months postoperatively, with a mean increase of 13.8 mm. A barely visible scar at the operation site was noted during the postoperative observation period, with no significant complications such as facial palsy or permanent occlusal disharmony. Conclusion: Subjective symptoms in all patients improved following the surgery. TMJ disc plication using MITEK mini anchors with our minimally invasive approach may be a feasible and effective surgical option for treating TMJ ID patients who are not responsive to conservative treatment.

• 대한통합의학회지
• /
• 제9권2호
• /
• pp.119-130
• /
• 2021

Purpose : We aimed to validate a new manual therapy to treat tension type headache(TTH) by applying myofascial release techniques to the scalp and to examine the changes in the quality of life and the headache characteristics after treatment and at the 6-month follow-up. Methods : Thirty patients were recruited in this study and were assigned to two groups through simple random sampling. Fifteen patients were assigned to the manual therapy group (MT) and 15 patients to the scalp myofascial release technique (SMT) group. However, five patients from the MT group and one from the SMT group were excluded. Therefore, 24 patients with TTH (10 males, 14 females) participated in the study. Patients underwent either MT or SMT. The procedures were performed by a physical therapist twice per week for 4 weeks. The quality of life [using the brief pain inventory (BPI) and the headache impact test (HIT)], and the frequency, duration, and intensity of the headache [on a visual analog scale (VAS)] were assessed before and after the treatment, and at the follow-up. Results : After 4 weeks of SMT, the frequency (p<.001), duration (p<.05), and intensity (p<.001) of the headache and the quality of life (HIT; p <.001, BPI; p<.001) significantly improved in the patients with TTH. The improvement in these parameters remained significant even after 6 months of follow-up. Similarly, After 4 weeks of MT, the frequency (p<.05), duration (p<.05), and intensity (p<.01) of the headache, and the quality of life (HIT; p<.05, BPI; p<.001) significantly improved in the patients with TTH. The improvement in these parameters remained significant even after 6 months of follow-up. There was no significant difference in these parameters between the two groups. Conclusion : It has been suggested that MT using the SMT can be used as a non-invasive treatment to treat the frequency, duration, and intensity of the TTH, and to improve the quality of life.

• 인간행동과 음악연구
• /
• 제16권1호
• /
• pp.25-46
• /
• 2019

본 연구는 중환자 보호자의 불안 감소를 위해 단회기 노래중심 음악치료를 적용한 예비연구로, 총 6명의 중환자 보호자가 음악치료 세션에 참여하였다. 노래중심 음악치료 중재는 초반에 대상자의 현재 정서 상태를 확인하고, 신체적 이완촉진 및 심리적 저항감을 줄이기 위한 음악듣기 혹은 음악에 맞추어 악기(톤차임)를 연주하는 단계를 진행하였고, 이후 노래중심 활동에서는 노래 가사에 대해서 토의하고 실제로 노래를 부르는 과정이 진행되었다. 가사에 대해 토의하면서 대상자가 자신에게 의미 있는 메시지를 확인할 수 있도록 하였고, 노래부르기 동안에는 연구자가 대상자의 정서 상태에 따라 음악 요소(템포, 다이내믹, 리듬, 화성 등)를 조정하며 제공하는 반주에 맞춰 선택된 노래를 부르도록 하였다. 대상자의 변화를 확인하기 위해 참여 전후로 상태불안 척도(STAI) 및 정서 상태에 대한 VAS 척도를 측정하였으며, 중재 과정에서 관찰된 대상자의 언어 반응 역시 분석하였다. 연구 결과, 중재 후 대상자들의 STAI 점수가 유의하게 감소한 것으로 나타났다. 또한 대상자들이 지각하는 정적 정서상태는 유의하게 증가하였고, 단회기 치료과정에서의 심리적 변화에는 개인적 편차가 있는 것으로 나타났다. 결과적으로 단회기 노래중심 음악치료가 중환자 보호자의 불안을 포함한 심리정서적 필요에 효과적으로 개입할 수 있는 가능성을 확인할 수 있었다.

• Journal of Dental Anesthesia and Pain Medicine
• /
• 제20권6호
• /
• pp.367-375
• /
• 2020

Background: Intraosseous anesthesia (IO) allows the anesthetic solution to be injected directly into the cancellous bone. The anesthetic solution immediately reaches the periapical region, and thus the axonal area of the nerve, where it can temporarily disable the sodium pump. The effect is felt almost without any time delay, and only a small amount of anesthetic solution is required. Methods: This study aims to investigate the efficacy of IO using the AnestoⓇ device after infiltration anesthesia (IA) and/or inferior alveolar nerve block anesthesia (IANB) failed to work in symptomatic irreversible pulpitis (hot tooth). The 33 patients included in the study were treated additionally with 1.7 ml articaine hydrochloride with 1:100,000 epinephrine hydrochloride (UltracainⓇ D-S, Sanofi-Aventis, Frankfurt, Germany) IO. Results: The electrical pulp test showed that 95.76% of the volunteers reacted positively to the combination of IANB or IA with the IO. In women, the additive IO was effective at 97.22%. In men, the IO led to pain elimination in 94.00% of cases. The duration of the IO was less than a quarter of an hour (13.03 min). The IO worked longer in women than in men (13.61 min vs. 12.33 min). Overall, more than every third tooth that needed trepanation was located in the posterior area of the mandible (36.4%). Treatment of hot teeth in this area was associated with an increased pulse rate and increased residual pain. There was a moderate correlation (Spearman-Rho [IRI] = 0.280) between the Visual Analog Scale (VAS) score and bone density, and a significant correlation (IRI = 0.612) between subjective residual pain and bone width. The IO resulted in a moderate, transient increase in the pulse rate by approximately 20 bpm. This is similar to the temporary increase in heart rate after conventional anesthesia techniques in non-preloaded patients and can be considered clinically irrelevant. Conclusion: IO with the AnestoⓇ device as an extension and deepening of local pain elimination is recommended for the treatment of hot teeth.

• 한국방사선학회논문지
• /
• 제16권6호
• /
• pp.787-797
• /
• 2022

본 연구는 온열·마사지 자극이 가능한 기계식 침대 적용을 통해 척추를 수직으로 자극하여, 파킨슨병의 통증 감소 및 증상 완화를 확인하고자 하였다. 이를 위해 파킨슨병 환자를 대상으로 의료용 조합자극 침대를 사용함에 따른 척추의 분절운동을 확인한 후 시각아날로그척도, 요통 기능 장애, 보행 능력, 나선형 그리기 검사를 실시하고 해당 변수 간의 관계를 파악하였다. 10일간의 시각아날로그척도, 요통 기능 장애 평가에서 침대 사용 후 평균이 감소하는 경향을 확인하였다. 보행 능력은 이동 시간의 감소와 이동 거리의 증가를 관찰하였다. 나선형 그리기 검사에서 침대 사용 후 검사 시간의 평균이 전보다 유의하게 낮았다. 그 결과, 기계식 온열 및 마사지로 척추 분절운동이 발생함에 따른 파킨슨병 환자의 회복 및 통증 완화를 위한 보조적인 방법으로 사용할 수 있는 가능성을 제시하였다. 그러나 본 연구는 예비적 연구로 피험자수가 적어 향후 피험자수와 상태를 세부적으로 고려한 추가적 연구가 필요하다.

• 한국환경성돌연변이발암원학회지
• /
• 제24권1호
• /
• pp.15-18
• /
• 2004

There are significant differences in the extent of drug interactions between subjects. The influence of the genetic make up of drug metabolizing enzyme activities (CYP3A5, CYP2C19 and UDP-glucuronosyl transferase) on the pharmacokinetic drug interaction potential were studied in vivo. Nineteen healthy volunteers were grouped with regard to the $CYP3A5^{*}3$ allele, into homozygous wild-type (CYP3A5^{*}1/1^{*}1$, n=6), heterozygous $(CYP3A5^{*}1/^{*}3$, n=6), and homozygous variant-type $(CYP3A5^{*}3/^{*}3$, n=7) subject groups. The pharmacokinetic profile of intravenous midazolam was characterized before and after itraconazole administration (200 mg once daily for 4 days), and also following rifampin pretreatment (600 mg once daily for 10 days), with a washout period of 2 weeks in between. For omeprazole and moclobemide pharmacokinetic interaction study 16 healthy volunteers were recruited. The volunteer group comprised 8 extensive metabolizers and 8 poor metabolizers of CYP2C19, which was confirmed by genotyping. Subjects were randomly allocated into two sequence groups, and a single-blind, placebo-controlled, two-period crossover study was performed. In study I, a placebo was orally administered for 7 days. On the eighth morning, 300 mg of moclobemide and 40 mg of placebo were coadministered with 200 mL of water, and a pharmacokinetic study was performed. During study n, 40 mg of omeprazole was given each morning instead of placebo, and pharmacokinetic studies were performed on the first and eighth day with 300 mg of moclobemide coadministration. In the UGT study pharmacokinetics and dynamics of 2 mg intravenous lorazepam were evaluated before and after rifampin pretreatment (600 mg once daily for 10 days), with a washout period of 2 weeks in between. The subjective and objective pharmacodynamic tests were done before and 1, 2, 4, 6, 8, and 12 hrs after lorazepam administration. The pharmacokinetic profiles of midazolam and of its hydroxy metabolites did not show differences between the genotype groups under basal and induced metabolic conditions. However, during the inhibited metabolic state, the $CYP3A5^{*}3/^{*}3$ group showed a greater decrease in systemic clearance than the $CYP3A5^{*}1/^{*}1$ group $(8.5\pm3.8$ L/h/70 kg vs. $13.5\pm2.7$ L/h/70 kg, P=0.027). The 1'-hydroxymidazolam to midazolam AUC ratio was also significantly lower in the $CYP3A5^{*}3/^{*}3$,/TEX> group $(0.58\pm0.35,$ vs. $1.09\pm0.37$ for the homozygous wild-type group, P=0.026). The inhibition of moclo-bemide metabolism was significant in extensive metabolizers even after a single dose of omeprazole. After daily administration of omeprazole for 1 week, the pharmacokinetic parameters of moclobemide and its metabolites in extensive metabolizers changed to values similar to those in poor metabolizers. In poor meta-bolizers, no remarkable changes in the pharmacokinetic parameters were observed. The area under the time-effect curves of visual analog scale(VAS), choice reaction time, and continuous line tracking test results of lorazepam was reduced by 20%, 7%, 23% respectively in induced state, and in spite of large interindividual variablity, significant statistical difference was shown in VAS(repeated measures ANOVA, p=0.0027).

• 한국환경성돌연변이발암원학회지
• /
• 제23권4호
• /
• pp.131-134
• /
• 2003

There are significant differences in the extent of drug interactions between subjects. The influence of the genetic make up of drug metabolizing enzyme activities (CYP3A5, CYP2C19 and UDP-glucuronosyl transferase) on the pharmacokinetic drug interaction potential were studied in vivo. Nineteen healthy volunteers were grouped with regard to the $CYP3A5^{*}3$ allele, into homozygous wild-type (CYP3A5^{*}1/1^{*}1$, n=6), heterozygous $(CYP3A5^{*}1/^{*}3$, n=6), and homozygous variant-type $(CYP3A5^{*}3/^{*}3$, n=7) subject groups. The pharmacokinetic profile of intravenous midazolam was characterized before and after itraconazole administration (200 mg once daily for 4 days), and also following rifampin pretreatment (600 mg once daily for 10 days), with a washout period of 2 weeks in between. For omeprazole and moclobemide pharmacokinetic interaction study 16 healthy volunteers were recruited. The volunteer group comprised 8 extensive metabolizers and 8 poor metabolizers of CYP2C19, which was confirmed by genotyping. Subjects were randomly allocated into two sequence groups, and a single-blind, placebo-controlled, two-period crossover study was performed. In study I, a placebo was orally administered for 7 days. On the eighth morning, 300 mg of moclobemide and 40 mg of placebo were coadministered with 200 mL of water, and a pharmacokinetic study was performed. During study n, 40 mg of omeprazole was given each morning instead of placebo, and pharmacokinetic studies were performed on the first and eighth day with 300 mg of moclobemide coadministration. In the UGT study pharmacokinetics and dynamics of 2 mg intravenous lorazepam were evaluated before and after rifampin pretreatment (600 mg once daily for 10 days), with a washout period of 2 weeks in between. The subjective and objective pharmacodynamic tests were done before and 1, 2, 4, 6, 8, and 12 hrs after lorazepam administration. The pharmacokinetic profiles of midazolam and of its hydroxy metabolites did not show differences between the genotype groups under basal and induced metabolic conditions. However, during the inhibited metabolic state, the $CYP3A5^{*}3/^{*}3$ group showed a greater decrease in systemic clearance than the $CYP3A5^{*}1/^{*}1$ group $(8.5\pm3.8$ L/h/70 kg vs. $13.5\pm2.7$ L/h/70 kg, P=0.027). The 1'-hydroxymidazolam to midazolam AUC ratio was also significantly lower in the $CYP3A5^{*}3/^{*}3$,/TEX> group $(0.58\pm0.35,$ vs. $1.09\pm0.37$ for the homozygous wild-type group, P=0.026). The inhibition of moclo-bemide metabolism was significant in extensive metabolizers even after a single dose of omeprazole. After daily administration of omeprazole for 1 week, the pharmacokinetic parameters of moclobemide and its metabolites in extensive metabolizers changed to values similar to those in poor metabolizers. In poor meta-bolizers, no remarkable changes in the pharmacokinetic parameters were observed. The area under the time-effect curves of visual analog scale(VAS), choice reaction time, and continuous line tracking test results of lorazepam was reduced by 20%, 7%, 23% respectively in induced state, and in spite of large interindividual variablity, significant statistical difference was shown in VAS(repeated measures ANOVA, p=0.0027).

• 대한정형외과 초음파학회지
• /
• 제7권1호
• /
• pp.1-6
• /
• 2014

목적: 동결견 환자에서 초음파를 통한 검사가 진단 및 치료 후 예후 판단에 객관적 자료로 쓰일 수 있는지 확인하고자, 진단 시 및 스테로이드 주사 치료 후 반대측과 비교 관찰하였다. 대상 및 방법: 저자들은 2012년 7월에서 2013년 7월 사이, line 1(CBT: 오구돌기-이두건)과 line 2(CBG: 오구돌기-이두건 고랑)를 이용한 초음파 검사를 통한 진단을 시행하였다. 대상이 된 20명의 환자에 대해 스테로이드 1회 주사 치료후 그 결과를 2, 4, 6개월의 추시 관찰을 통하여 초음파 연속 검사 상 참고선의 호전 정도 및 견관절 운동 범위 회복 정도를 비교하였다. 결과: 초음파 검사상 환측과 건측의 차이는 치료 전 CBT이 중립, 외회전, 내회전에서 각각 -5.6 mm, -5.0 mm, -4.3 mm였으며 CBG는 -6.1 mm, -4.7 mm, -5.0 mm이었으며(p<0.05), 2개월(CBT: -4.8 mm, -3.5 mm, -2.6 mm/CBG: -4.7 mm, -4.0 mm, -3.6 mm), 4개월(CBT: -4.7 mm, -3.2 mm, -1.7 mm/CBG: -4.3 mm, -3.7 mm, -1.2 mm), 6개월(CBT: -1.1 mm, -2.9 mm, -0.5 mm / CBG: -1.2 mm, -0.7 mm, -0.9 mm)로써 내회전은 4개월, 중립 및 외회전은 6개월 이후 호전되는 소견을 보였다(p<0.05). 운동 범위는 치료 전 전방거상, 외회전, 내회전이 108도, 32도, L5, 2개월에는 117도, 35도, L4, 4개월에는 133도, 42도, L3, 6개월에는 136도, 47도, L2로써 4개월 이후 유의한 회복소견을 보였다. 시각통증등급(VAS)은 치료전 7.5에서 2개월에는 3.0으로 유의한 호전을 보였다(p<0.05). 결론: 스테로이드 주사 치료 후 참고선은 6개월 후 회복되는 소견을 보여, 운동 범위는 4개월 후, 통증은 2개월 후 호전을 보인 것에 비해 다소 지연되어 나타나는 경향이었다. 동적 초음파 검사는 동결견 환자에서 진단 및 예후 판단 시 유효한 검사 방법으로 이용할 수 있을 것으로 생각되었다.